Clinical trials recruiting for Moderate-to-severe Atopic Dermatitis

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
  NCT07558668 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 14 locations
• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
  NCT07711418 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 13 locations
• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
  NCT07690371 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 19 locations
• A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis
  NCT07211542 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
  NCT06239311 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations
• Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis
  NCT07370909 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis
  NCT07660835 · Phase: Phase 2 · Ages: 6 Months to 23 Months · Sex: All (male and female) · 1 location
• Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
  NCT06934252 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 19 locations
• Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
  NCT06723080 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis
  NCT03057860 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 3 locations

Related conditions

Trials recruiting for Moderate-to-severe Atopic Dermatitis often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Moderate-to-severe Atopic Dermatitis trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.